價格 | ¥10600 | ¥17500 | ¥13800 |
包裝 | 25mg | 100mg | 50mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-02-28 |
中文名稱:化合物 Mitiglinide | 英文名稱:Mitiglinide |
CAS:145375-43-5 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號: T21431 |
Name | Mitiglinide |
Description | Mitiglinide (KAD-1229) is an insulinotropic agent that is an ATP-sensitive K + (K ATP ) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell K ATP channel). Mitiglinide is able to be used for the research of type 2 diabetes [1] [2]. |
In vitro | In COS-1 cells, Mitiglinide inhibits the Kir6.2/SUR1 channel currents in a dose-dependent manner (IC 50 of 100 nM) but does not significantly inhibit either Kir6.2/SUR2A or Kir6.2/SUR2B channel currents even at high doses (over 10 μM) [1]. |
In vivo | Mitiglinide (1-3 mg/kg; p.o.) inhibits the increase of plasma glucose levels seen after a meal load and the area under the curve for plasma glucose levels (AUCglucose) up to 5 h after the meal load [2]. Animal Model: Pregnant Wistar rats (12 weeks) [2] Dosage: 0.3 mg/kg, 1 mg/kg, 3 mg/kg Administration: Oral administration Result: Dose-dependently suppressed AUC glucose levels. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | Mitiglinide |
成立日期 | 2013-04-18 (13年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報(bào)價日期 | |
---|---|---|---|---|
詢價 |
VIP6年
|
湖北威德利化學(xué)試劑有限公司
|
2025-04-10 | |
詢價 |
VIP1年
|
陜西西化化學(xué)工業(yè)有限公司
|
2025-03-06 | |
詢價 |
Linyi Shengxin Pharmaceutical R&D Co., Ltd
|
2024-03-03 |